相关实验视频

Updated: Jul 16, 2025

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

长期暴露于二硫化碳会通过α-synuclein聚合和体复合相互作用诱导帕金森病理

Zhidan Liu¹, Kang Kang², Shulin Shan¹

¹Department of Toxicology and Nutrition, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China.

|September 21, 2023

概括

二硫化碳 (CS2) 暴露会通过损害大脑细胞引起帕金森症. 这项研究揭示了CS2诱导的α-synuclein聚合会触发细胞死亡途径,导致运动障碍.

科学领域:

神经科学是一个神经科学.
毒理学毒理学毒理学
细胞生物学细胞生物学

背景情况:

职业接触二硫化碳 (CS2) 与帕金森症有关.
驱动CS2诱导的神经退行症的精确机制尚未完全理解.

研究的目的:

在老鼠模型上研究慢性CS2暴露的病理影响.
阐明CS2诱导的帕金森病理背后的分子机制.

主要方法:

鼠被暴露在CS2中以诱导慢性毒性.
行为测试评估了运动功能.
免疫组织化学和免疫测试分析了神经元损伤,α-synuclein聚合和亡标志物 (RIP1,RIP3,MLKL).
在体外和体内研究中,研究了α-synuclein和体复合体的作用.

主要成果:

对CS2的暴露导致了 substantia nigra pars compacta (SNpc) 中显著的运动缺陷和多巴胺类神经元的损失.
CS2诱导了α-synuclein聚合和酸化,同时激活了SNPc中的亡.
聚合的α-synuclein与体复合体 (RIP1,RIP3,MLKL) 之间的相互作用被确定为神经元细胞死亡的关键驱动因素.

结论:

通过α-synuclein聚合,CS2暴露会触发帕金森病理.
这种聚合激活了亡,导致多巴氨基神经元损失和运动障碍.
这些发现突出了一个新的机制,通过α-synuclein-necrosome通路将CS2毒性与帕金森症联系起来.

关键词:

生物化学生物化学生物科学生物科学细胞生物学细胞生物学神经科学是一个神经科学.

更多相关视频

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...